Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

Current Opinion in Virology
Max Crispin, Katie J Doores

Abstract

The surface of enveloped viruses can be extensively glycosylated. Unlike the glycans coating pathogens such as bacteria and fungi, glycans on viruses are added and processed by the host-cell during biosynthesis. Glycoproteins are typically subjected to α-mannosidase processing and Golgi-mediated glycosyltransferase extension to form complex-type glycans. In envelope viruses, exceptions to this default pathway are common and lead to the presence of oligomannose-type glycan structures on the virion surface. In one extreme example, HIV-1 utilises a high density of glycans to limit host antibody recognition of protein. However, the high density limits glycan processing and the resulting oligomannose structures can be recognised by broadly neutralising antibodies isolated from HIV-1 infected patients. Here we discuss how divergence from host-cell glycosylation can be targeted for vaccine design.

References

Jan 1, 1997·Critical Reviews in Biochemistry and Molecular Biology·P M Rudd, R A Dwek
Nov 21, 2001·British Medical Bulletin·B KorberV Detours
Apr 30, 2003·Antiviral Research·Laura G BarrientosMichael R Boyd
Nov 7, 2007·The Journal of Biological Chemistry·Alex S PowleslandKurt Drickamer
Oct 4, 2008·AIDS·D Cameron DunlopChristopher N Scanlan
Jun 6, 2009·Journal of Virology·Thomas A BowdenDavid I Stuart
Jun 6, 2009·The Journal of General Virology·Kari HackerAravinda M de Silva
Apr 2, 2010·Nature Reviews. Drug Discovery·Rena D Astronomo, Dennis R Burton
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Cory L BrooksStephen V Evans
Jul 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Katie J DooresChristopher N Scanlan
Jul 30, 2010·Journal of Virology·Gabrielle VieyresJean Dubuisson
May 25, 2011·The Journal of Infectious Diseases·Wanwisa DejnirattisaiGavin Screaton
Jul 20, 2011·Cell Host & Microbe·Pierre-Yves LozachAri Helenius
Oct 23, 2012·Cell Host & Microbe·Dennis R BurtonRichard Wyatt
Oct 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Brian MoldtDennis R Burton
Nov 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hugo MouquetPamela J Bjorkman
Feb 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jean-Philippe JulienAndrew B Ward
May 28, 2013·Nature Structural & Molecular Biology·Leopold KongIan A Wilson
May 28, 2013·Nature Structural & Molecular Biology·Marie PanceraPeter D Kwong
Jul 9, 2013·Nature Chemical Biology·Mohammed N AminLai-Xi Wang
Aug 24, 2013·Nature Reviews. Immunology·Peter D KwongGary J Nabel
Aug 29, 2013·Nature Structural & Molecular Biology·Max Crispin, Thomas A Bowden
Nov 2, 2013·Science·Jean-Philippe JulienIan A Wilson
Nov 30, 2013·Science·Leopold KongMansun Law
Jan 28, 2014·Current Opinion in Chemical Biology·Lai-Xi Wang
Jan 29, 2014·Journal of Proteome Research·Max CrispinThomas A Bowden

❮ Previous
Next ❯

Citations

Sep 29, 2015·The FEBS Journal·Katie J Doores
Nov 3, 2015·Reviews in Medical Virology·Sigvard OlofssonHans H Wandall
Mar 10, 2016·Journal of Mass Spectrometry : JMS·David J HarveyJim Scrivens
Mar 22, 2016·Cell Host & Microbe·Christian KrappFrank Kirchhoff
Apr 23, 2016·Current Opinion in Virology·Max CrispinThomas A Bowden
Jan 31, 2017·Immunological Reviews·Thomas B Kepler, Kevin Wiehe
Mar 4, 2017·Current Opinion in HIV and AIDS·David Peterhoff, Ralf Wagner
Jan 23, 2016·Chemical Society Reviews·Qi-Ying HuRoberto Adamo
Mar 7, 2018·Journal of the American Society for Mass Spectrometry·David J HarveyWeston B Struwe
Jun 19, 2015·Journal of Virology·Laura K PritchardKatie J Doores
May 22, 2019·Journal of the American Society for Mass Spectrometry·Vera B IvlevaQ Paula Lei
Feb 4, 2016·Retrovirology·Stefanie A KrummKatie J Doores
Sep 6, 2017·Expert Review of Proteomics·Anna-Janina BehrensMax Crispin
Apr 10, 2019·Polymers·Shashank Reddy PinnapireddyUdo Bakowsky
Apr 29, 2020·Expert Opinion on Therapeutic Targets·Thandeka MoyoPenny L Moore
Dec 9, 2016·Glycoconjugate Journal·Cassandra L PeggJeffrey J Gorman
Mar 30, 2018·Annual Review of Biophysics·Max CrispinIan A Wilson
Jun 20, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Madina ShakirzyanovaCecilia Cheng-Mayer
Jul 28, 2019·Vaccines·Karl SteficFrancis Barin
Jan 16, 2017·Virology Journal·Mamneet MangheraRenée N Douville
Aug 21, 2019·Trends in Biotechnology·Peter HraberJeanne M Fair
Jul 9, 2021·Analytical and Bioanalytical Chemistry·Asif ShajahanParastoo Azadi
Jun 7, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Tomas BertokJan Tkac
Aug 24, 2021·The Journal of General Virology·Phoebe Stevenson-LeggettErica Bickerton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.